HealthLeaders Media August 1, 2023
The payer forecasts that its star ratings in the private program could suffer further after a difficult 2022.
KEY TAKEAWAYS
– On a second-quarter earnings call with investors, Centene CEO Sarah London said the company is anticipating it will lose its only four-star Medicare Advantage contract.
– The insurer experienced declines across its star rating plans for 2023, but expects to see progression in its three- and 3.5-star plans in October.
– Meanwhile, marketplace membership growth and steady Medicaid performance amid the redetermination process led to the payer netting $1.1 billion in earnings for the second quarter.
Centene could soon be without any four-star Medicare Advantage (MA) contracts, CEO Sarah London told investors in the company’s second-quarter earnings call.
After...
Today's Sponsors
Today's Sponsor